JMCP Findings - Optimizing the Management of Inherited Blood Disorders Part 2

Topic(s):

Market Insights , Inherited Blood Disorder

FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | July, 2024

Summary

Health care leaders will need plans for handling new treatments for inherited blood disorders. This might mean changing benefits for treatments to make sure patients can get gene therapy. People with inherited blood disorders are better off when they get care from different types of health care providers. Using systems like registries to keep track of how treatments affect health and business agreements is important. These kinds of steps are important for figuring out how well new treatments work over a long time, making decisions, and managing costs for inherited blood disorders.

For more disease state research, view the Market Insights Program.